Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma. Presented at the 11th International Symposium on Hodgkin Lymphoma. Abstract #0116 | 2018 | |||
First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi | Blood Cancer Journal |
| 32 | 2019 |
10.1016/S0140-6736(15)60165-9 | ||||
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma | Blood Journal |
| 283 | 2016 |
10.1200/JCO.2011.38.0410 |